TGM3, as a candidate tumor suppressor, contributes to the carcinogenesis and development of HNC. »
12/01/13

Novel epigenetic markers for colon cancer identified and assessed for their combined use for diagnostic accuracy. »
12/01/13

Validation of association between reported SNPs and breast cancer risk in the Japanese population. »
12/01/13

Myxofibrosarcoma mainly affect patients in the sixth to eighth decades of life and the overall 5-year survival rate is 60--70%. »
12/01/13

While recent research has shown that expression of ZEB-1 in a variety of tumors has a crucial impact on patient survival, there is little information regarding ZEB-1 expression in hepatocellular carcinoma (HCC). This study investigated the co-expression of ZEB-1 and E-cadherin in HCC by immunohistochemistry and evaluated its association with clinical factors, including patient prognosis. »
12/05/13

Flotillins may not be suitable as cancer therapy targets because knockdown may facilitate cancer cellgrowth and proliferation by other entities. »
12/05/13

Recent research on the cancer-specific role of glycolytic enzymes including their non-glycolytic functions. »
12/03/13

Intratumoral co-administration of SLC and anti-CD25 mAbs was an effective treatment for HCC. »
12/05/13

Mitochondrial DNA D-Loop mutations may play a significant role in the etiology of bladder cancer. »
12/05/13

LF-MF can inhibit the proliferation and metastasis of melanoma and influence immune function. »
12/06/13